• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人群经皮冠状动脉介入治疗的预后:多中心前瞻性e-ULTIMASTER注册研究结果

Prognosis of PCI in the Older Adult Population: Outcomes From the Multicenter Prospective e-ULTIMASTER Registry.

作者信息

Saada Majdi, Kobo Ofer, Kauer Floris, Sakhov Orazbek, Laanmets Peep, Abhaichand Rajpal, Lozano Iñigo, Crowley Jim, Wander Gurupreet Singh, Mamas Mamas A, Roguin Ariel

机构信息

Hillel Yaffe Medical Center, Technion-Faculty of Medicine, Israel.

Department of Cardiology, Albert Schweitzer Ziekenhuis, Dordrecht, the Netherlands.

出版信息

J Soc Cardiovasc Angiogr Interv. 2022 Aug 24;1(5):100442. doi: 10.1016/j.jscai.2022.100442. eCollection 2022 Sep-Oct.

DOI:10.1016/j.jscai.2022.100442
PMID:39131453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11308062/
Abstract

BACKGROUND

Older adult patients undergoing percutaneous coronary intervention (PCI) are usually excluded from clinical trials. This study aimed to assess 1-year clinical outcomes in patients aged >80 years.

METHODS

This all-comer registry included patients who underwent PCI using the Ultimaster stent. Primary clinical endpoint was target lesion failure (TLF), a composite of cardiac death (CD), target vessel-related myocardial infarction (TV-MI), or clinically indicated target lesion revascularization (CD-TLR).

RESULTS

In total, 3286 (8.8%) patients aged ≥80 years were compared with 33,912 patients aged <80 years. The older adult patients included more women, had more comorbidities and exhibited more complex coronary anatomy. The incidence of TLF was higher in the older adult group (5.6% vs 3.0%, < .0001), as well as for all-cause mortality (6.2% vs 1.7%, < .0001), CD (3.3% vs 1.1%, < .0001), and TV-MI (1.7% vs 0.8%, < .0001), but not for CD-TLR (1.9% vs 1.7%, = .15). After the inverse propensity score weighted analysis, aged ≥80 years was associated with increased risk of TLF (HR, 1.42; 95% CI, 1.22-1.66; < .0001), CD (HR, 1.67; 95% CI, 1.136-2.06; < .0001), and TV-MI (HR, 1.66; 95% CI, 1.24-2.24; < .001) but not for CD-TLR (HR, 1.10; 95% CI, 0.85-1.43; = .45).

CONCLUSION

Older adult patients had a higher incidence of TLF, CD, and TV-MI but with no difference in the incidence of recurrent revascularization or stent thrombosis. Although PCI in older adults is relatively safe, higher rates of cardiac events should be considered.

摘要

背景

接受经皮冠状动脉介入治疗(PCI)的老年患者通常被排除在临床试验之外。本研究旨在评估80岁以上患者的1年临床结局。

方法

该全人群注册研究纳入了使用Ultimaster支架接受PCI的患者。主要临床终点是靶病变失败(TLF),这是一个由心源性死亡(CD)、靶血管相关心肌梗死(TV-MI)或临床指征的靶病变血运重建(CD-TLR)组成的复合终点。

结果

总共将3286例(8.8%)年龄≥80岁的患者与33912例年龄<80岁的患者进行了比较。老年患者中女性更多,合并症更多,冠状动脉解剖结构更复杂。老年组的TLF发生率更高(5.6%对3.0%,P<0.0001),全因死亡率(6.2%对1.7%,P<0.0001)、CD(3.3%对1.1%,P<0.0001)和TV-MI(1.7%对0.8%,P<0.0001)也是如此,但CD-TLR发生率无差异(1.9%对1.7%,P=0.15)。在进行倾向评分逆加权分析后,年龄≥80岁与TLF风险增加相关(HR,1.42;95%CI,1.22-1.66;P<0.0001)、CD(HR,1.67;95%CI,1.136-2.06;P<0.0001)和TV-MI(HR,1.66;95%CI,1.24-2.24;P<0.001),但CD-TLR无差异(HR,1.10;95%CI,0.85-1.43;P=0.45)。

结论

老年患者的TLF、CD和TV-MI发生率较高,但再次血运重建或支架血栓形成的发生率无差异。虽然老年患者的PCI相对安全,但应考虑较高的心脏事件发生率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2712/11308062/90093d1e8c36/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2712/11308062/199a19910287/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2712/11308062/f80e654b79d2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2712/11308062/4d86056ba3e2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2712/11308062/2391ef87ba0d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2712/11308062/64b76d8c3601/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2712/11308062/90093d1e8c36/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2712/11308062/199a19910287/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2712/11308062/f80e654b79d2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2712/11308062/4d86056ba3e2/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2712/11308062/2391ef87ba0d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2712/11308062/64b76d8c3601/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2712/11308062/90093d1e8c36/figs1.jpg

相似文献

1
Prognosis of PCI in the Older Adult Population: Outcomes From the Multicenter Prospective e-ULTIMASTER Registry.老年人群经皮冠状动脉介入治疗的预后:多中心前瞻性e-ULTIMASTER注册研究结果
J Soc Cardiovasc Angiogr Interv. 2022 Aug 24;1(5):100442. doi: 10.1016/j.jscai.2022.100442. eCollection 2022 Sep-Oct.
2
Prognosis of PCI in AMI setting in the elderly population: Outcomes from the multicenter prospective e-ULTIMASTER registry.老年人群急性心肌梗死患者经皮冠状动脉介入治疗的预后:多中心前瞻性 e-ULTIMASTER 注册研究结果。
Clin Cardiol. 2022 Dec;45(12):1211-1219. doi: 10.1002/clc.23902. Epub 2022 Sep 7.
3
[Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 5-year results of the TARGET Ⅱ trial].[一种新型腔内凹槽填充可生物降解聚合物西罗莫司洗脱支架治疗初发冠状动脉病变的安全性和有效性:TARGETⅡ试验5年结果]
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Jul 24;46(7):523-528. doi: 10.3760/cma.j.issn.0253-3758.2018.07.004.
4
Impact of peripheral artery disease on prognosis after percutaneous coronary intervention: Outcomes from the multicenter prospective e-ULTIMASTER registry.外周动脉疾病对经皮冠状动脉介入治疗后预后的影响:多中心前瞻性e-ULTIMASTER注册研究结果
Atherosclerosis. 2022 Mar;344:71-77. doi: 10.1016/j.atherosclerosis.2022.01.007. Epub 2022 Jan 25.
5
Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.药物涂层支架治疗支架内再狭窄患者的临床结果:一项汇总分析的 2 年结果。
JACC Cardiovasc Interv. 2013 Sep;6(9):905-13. doi: 10.1016/j.jcin.2013.04.017. Epub 2013 Aug 14.
6
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry).ULISSE 注册研究(意大利 ULtimaster 多中心所有入组患者支架注册研究):糖尿病患者中生物可降解聚合物西罗莫司洗脱支架一年临床预后结果。
Catheter Cardiovasc Interv. 2020 Aug;96(2):255-265. doi: 10.1002/ccd.28694. Epub 2020 Jan 6.
7
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry.急性心肌梗死患者应用生物可降解聚合物西罗莫司洗脱支架的 1 年临床结果:ULISSE 注册研究的见解。
Catheter Cardiovasc Interv. 2019 Dec 1;94(7):972-979. doi: 10.1002/ccd.28305. Epub 2019 Apr 29.
8
Treatment of Ostial Right Coronary Artery Narrowings: Outcomes From the Multicenter Prospective e-ULTIMASTER Registry.右冠状动脉开口狭窄的治疗:多中心前瞻性e-ULTIMASTER注册研究的结果
J Soc Cardiovasc Angiogr Interv. 2023 Feb 25;2(3):100604. doi: 10.1016/j.jscai.2023.100604. eCollection 2023 May-Jun.
9
Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials.新一代药物洗脱支架的复杂与非复杂经皮冠状动脉介入治疗:来自随机 BIOFLOW 试验的分析。
Clin Res Cardiol. 2022 Jul;111(7):795-805. doi: 10.1007/s00392-022-01994-4. Epub 2022 Feb 25.
10
One-year clinical outcomes in patients with chronic kidney disease treated with COMBO stents: From the COMBO collaboration.使用COMBO支架治疗的慢性肾病患者的一年临床结局:来自COMBO协作组。
Catheter Cardiovasc Interv. 2020 Sep 16. doi: 10.1002/ccd.29270.

引用本文的文献

1
Intravascular lithotripsy for the treatment of calcified coronary lesions in individuals of advanced age: a post-hoc analysis of the multicentre, prospective BENELUX-IVL study.血管内碎石术治疗高龄患者钙化性冠状动脉病变:多中心前瞻性比荷卢血管内碎石术(BENELUX-IVL)研究的事后分析
EClinicalMedicine. 2025 Jul 4;85:103342. doi: 10.1016/j.eclinm.2025.103342. eCollection 2025 Jul.
2
Bleeding Risk in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Comprehensive Review.老年患者经皮冠状动脉介入治疗的出血风险:一项综合综述。
J Clin Med. 2025 Feb 12;14(4):1194. doi: 10.3390/jcm14041194.
3
Sex Differences in Patients Undergoing Left Main Stem Percutaneous Coronary Intervention for Stable Angina: Data From a National Registry.

本文引用的文献

1
Cardiovascular care of older adults.老年人的心血管保健。
BMJ. 2021 Aug 31;374:n1593. doi: 10.1136/bmj.n1593.
2
RESEARCHWhen It Comes to Older Adults, Language Matters and Is Changing: American Geriatrics Society Update on Reframing Aging Style Changes.研究:对于老年人而言,语言很重要且正在发生变化:美国老年医学会关于重塑衰老风格变化的最新情况
J Am Geriatr Soc. 2021 Jan;69(1):265-267. doi: 10.1111/jgs.16848. Epub 2020 Sep 30.
3
New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials.
稳定型心绞痛患者行左主干经皮冠状动脉介入治疗的性别差异:来自全国注册登记研究的数据。
J Am Heart Assoc. 2024 Nov 19;13(22):e036569. doi: 10.1161/JAHA.124.036569. Epub 2024 Nov 15.
4
Predictors of major adverse cardiac and cerebrovascular events after percutaneous coronary intervention in older adults: a systematic review and meta-analysis.老年患者经皮冠状动脉介入治疗后主要心脑血管不良事件的预测因素:系统评价和荟萃分析。
BMC Geriatr. 2024 Apr 12;24(1):337. doi: 10.1186/s12877-024-04896-4.
5
Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis.老年人经皮冠状动脉介入治疗后缩短双联抗血小板治疗:系统评价和网络荟萃分析。
JAMA Netw Open. 2024 Mar 4;7(3):e244000. doi: 10.1001/jamanetworkopen.2024.4000.
新一代药物洗脱冠状动脉支架在 80 岁以上患者中的应用:TWENTE I-IV 试验的患者水平汇总分析。
Am Heart J. 2020 Oct;228:109-115. doi: 10.1016/j.ahj.2020.07.003. Epub 2020 Jul 12.
4
Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study.缺血性心脏病的全球流行病学:全球疾病负担研究结果
Cureus. 2020 Jul 23;12(7):e9349. doi: 10.7759/cureus.9349.
5
Proximal Left Anterior Descending Artery Treatment Using a Bioresorbable Polymer Coating Sirolimus-Eluting Stent: Real-World Outcomes From the Multicenter Prospective e-Ultimaster Registry.近端左前降支动脉采用生物可吸收聚合物涂层依维莫司洗脱支架治疗:多中心前瞻性 e-Ultimaster 注册研究的真实世界结果。
J Am Heart Assoc. 2019 Dec 3;8(23):e013786. doi: 10.1161/JAHA.119.013786. Epub 2019 Nov 30.
6
Comparison of Outcomes After Percutaneous Coronary Intervention in Elderly Patients, Including 10 628 Nonagenarians: Insights From a Japanese Nationwide Registry (J-PCI Registry).比较老年患者(包括 10628 名 90 岁以上老人)经皮冠状动脉介入治疗的结果:来自日本全国注册登记研究(J-PCI 注册登记研究)的分析。
J Am Heart Assoc. 2019 Mar 5;8(5):e011183. doi: 10.1161/JAHA.118.011017.
7
Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial.老年冠心病患者药物洗脱支架的研究(SENIOR):一项随机单盲试验
Lancet. 2018 Jan 6;391(10115):41-50. doi: 10.1016/S0140-6736(17)32713-7. Epub 2017 Nov 1.
8
Temporal Trends, Complications, and Predictors of Outcomes Among Nonagenarians Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.90 岁以上人群行经皮冠状动脉介入治疗的时间趋势、并发症和结局预测因素:来自退伍军人事务临床评估、报告和跟踪计划的见解。
JACC Cardiovasc Interv. 2017 Jul 10;10(13):1295-1303. doi: 10.1016/j.jcin.2017.03.051.
9
Safety and efficacy outcomes of second-generation everolimus-eluting stents in octogenarians compared to non-octogenarians.与非八旬老人相比,第二代依维莫司洗脱支架在八旬老人中的安全性和有效性结果。
Cardiovasc Revasc Med. 2018 Jan;19(1 Pt A):12-16. doi: 10.1016/j.carrev.2017.05.022. Epub 2017 Jun 1.
10
Drug-coated versus bare-metal stents for elderly patients: A predefined sub-study of the LEADERS FREE trial.老年患者使用药物涂层支架与裸金属支架的比较:LEADERS FREE试验的一项预设亚研究。
Int J Cardiol. 2017 Sep 15;243:110-115. doi: 10.1016/j.ijcard.2017.04.079. Epub 2017 Apr 25.